**Core tip:** We report two typical cases of unicentric Castleman disease (UCD) presenting as a retroperitoneal peripancreatic mass. The clinical manifestations and imaging findings of these masses were nonspecific. UCD is difficult to diagnose prior to surgery, and the diagnosis is mainly by postoperative pathological examination. The occurrence of UCD in the abdominal cavity is very rare, especially in the retroperitoneal peripancreatic region. Importantly, both patients recovered well without postoperative radiochemotherapy. These case reports provide a valuable reference for the diagnosis and treatment of this disease.

INTRODUCTION
============

Castleman disease (CD) is generally identified as a polyclonal lymphoid proliferation of unknown etiology, and is also known as angiofollicular lymph node hyperplasia. It was first described by Benjamin Castleman in 1954 as "localized mediastinal lymph node hyperplasia resembling thymoma", and was named after him\[[@B1]\]. This disease can occur in any age group, but is mostly seen in patients aged 30-50 years, with no significant gender differences\[[@B2]\]. Clinically, the disease is divided into two major types: unicentric CD (UCD) and multicentric CD, based on its locations at a single lymph node and a series of lymph nodes, respectively\[[@B3]\]. CD, which develops in all lymph nodes, especially in the mediastinum, can also occur in the cervical, retroperitoneal, and axillary regions. However, invasion into the retroperitoneal peripancreatic region is quite rare\[[@B4]\]. We herein report two rare cases of retroperitoneal peripancreatic UCD over a three-year period from 2014 to 2017.

CASE REPORT
===========

Case 1
------

A 48 year old woman was referred to our department on April 28, 2014 for a detailed physical examination due to retroperitoneal peripancreatic lymph node enlargement over seven days. The patient initially had no apparent discomfort or noteworthy positive signs. Magnetic resonance imaging (MRI) of the epigastrium showed an elliptical hyperintense signal below the pancreas on the T1 weighted image (T1WI) (Figure [1B](#F1){ref-type="fig"}). The size of the lesion was 3.0 cm × 1.9 cm with a clear boundary, with slight hyperintensity on the fat-suppression T2 weighted image (T2WI) (Figure [1C](#F1){ref-type="fig"}). In addition, marked enhancement on the arterial phase (Figure [1D](#F1){ref-type="fig"} and E) and reduced enhancement on the delayed phase (Figure [1F](#F1){ref-type="fig"}) were observed, which were probably due to lymph node enlargement. Laboratory examinations revealed that the patient was negative for the human immunodeficiency virus (HIV) antibody. Tumor markers and other laboratory test results were also within the normal range.

![Magnetic resonance imaging of the lesion (yellow arrow) in Case 1. A: Coronal T2-weighted image sequence; B: Transverse T1-weighted fat-suppression sequence; C: Transverse T2-weighted fat-suppression sequence; D: Transverse T1-weighted fat-suppression sequence (early arterial phase); E: Transverse T1-weighted fat-suppression sequence (late arterial phase); F: Transverse T1-weighted fat-suppression sequence (delayed phase).](WJG-24-3958-g001){#F1}

Based on the above results, a retroperitoneal peripancreatic mass was diagnosed preoperatively. Laparotomy was performed through an oblique incision along the left lower rib, and no ascites were found. When the gastrocolic ligament was incised, a tumor was discovered closely adhered to the lower edge of the pancreas (Figure [2A](#F2){ref-type="fig"}). The tumor volume was 3.0 cm × 2.0 cm × 2.0 cm, had a soft flexible texture and a clear boundary (Figure [2B](#F2){ref-type="fig"}). The tumor was completely removed with blunt and sharp separation for further testing (Figure [2C](#F2){ref-type="fig"}). Lymphoid tissue hyperplasia was identified in a frozen biopsy. Postoperative pathology indicated that the retroperitoneal peripancreatic single lymph node was compatible with CD (Figure [3B](#F3){ref-type="fig"}-D). Immunohistochemical staining revealed that cells were slightly positive for CD20, CD3, CD21, bcl-6, and bcl-2, a small number of cells were positive for CD138, and 20% of cells were positive for Ki-67. During the follow-up at 30 mo after surgery, the patient was recovering well with no signs of recurrence.

![Surgery of the retroperitoneal peripancreatic unicentric Castleman disease in Case 1. A: The tumor was close to the lower side of the pancreas with a clear margin and a volume of 3 cm × 2 cm × 2 cm; B: Image of the free tumor; C: The tumor was completely excised.](WJG-24-3958-g002){#F2}

![Pathological examinations of the tumor in Case 1. A: The tumor was 3 cm × 2 cm × 2 cm in size. It had a smooth surface, complete envelope, and was white to tan in appearance; B: Pathological section analysis of UCD (HE, × 100); C: Pathological section analysis of UCD (HE, × 200); D: Pathological section analysis of UCD (HE, × 400). HE: Hematoxylin and eosin; UCD: Unicentric Castleman disease.](WJG-24-3958-g003){#F3}

Case 2
------

A 57 year old woman was admitted to our hospital on July 18, 2017 because of tiredness and fever. The patient had a body temperature of 39 degrees without other discomfort. Physical examination indicated no positive symptoms. MRI of the epigastrium showed that there was an elliptical hyperintense signal below the pancreas on the T1WI (Figure [4A](#F4){ref-type="fig"}) and slight hyperintensity on the fat-suppression T2WI (Figure [4B](#F4){ref-type="fig"}). The internal signal was heterogeneous and a clearly bounded tumor 3.4 cm × 2.8 cm in size was observed. Marked enhancement on the arterial phase was inhomogeneous (Figure [4C](#F4){ref-type="fig"}). In addition, the venous phase and delayed phase continued to intensify (Figure [4D](#F4){ref-type="fig"}-F). On account of the hypervascular mass located under the pancreas, it was highly possible that the mass was a nerve incretory tumor.

![Magnetic resonance imaging of the lesion (yellow arrow) in Case 2. A: Transverse T1-weighted fat-suppression sequence; B: Transverse T2-weighted fat-suppression sequence; C: Transverse T1-weighted fat-suppression sequence (arterial phase); D: Transverse T1-weighted fat-suppression sequence (venous phase); E: Transverse T1-weighted fat-suppression sequence (delayed phase); F: Coronal T1-weighted fat-suppression sequence (delayed phase).](WJG-24-3958-g004){#F4}

Laboratory examinations showed that the HIV antibody was negative and the white blood cell count was 14.6 × 10^9^/L. Tumor markers and other laboratory test results were within the normal range. The preoperative diagnosis was an retroperitoneal neuroendocrine tumor. Laparoscopic surgery was performed to remove the retroperitoneal tumor. No ascitic fluid or obvious conglutination were found. When the gastrocolic ligament was incised, the lesion was located behind and below the transverse mesocolon. Intraoperative ultrasonography indicated that the tumor had an abundant blood supply, and its right side was close to the inferior mesenteric artery and vein (Figure [5A](#F5){ref-type="fig"}). The flexible tumor was 3.0 cm × 3.0 cm in size with a clear border (Figure [5B](#F5){ref-type="fig"}). The tumor was completely removed by blunt and sharp separation for further analysis (Figure [5C](#F5){ref-type="fig"}). Rapid histopathological examination revealed that the mass was possibly retroperitoneal CD together with a follicular dendritic cell tumor, which was confirmed by subsequent postoperative pathology (Figure [6B](#F6){ref-type="fig"}-F). Immunohistochemical staining showed that a portion of cells were positive for CD21 and negative for CK, a small number of cells were positive for S-100 and slightly positive for CD1a and CD23, and about five percent of cells were positive for Ki67. The patient recovered well after surgery without chemotherapy, and no relapse was found during the follow-up period.

![Surgery of the retroperitoneal peripancreatic unicentric Castleman disease in Case 2. A: The lesion was located below and behind the transverse mesocolon with a volume of 3.5 cm × 3 cm × 3 cm. Intraoperative ultrasonography indicated that the tumor had an abundant blood supply, and its right side was close to the inferior mesenteric artery and vein; B: Image of the free tumor; C: The tumor was completely excised.](WJG-24-3958-g005){#F5}

![Pathological examinations of the tumor in Case 2. A: The tumor was 3.5 cm × 3 cm × 3 cm in size. It had a smooth surface, complete envelope, and was white to tan in appearance; B: Pathological section analysis of UCD (HE, × 100); C: Pathological section analysis of UCD (HE, × 200); D: Pathological section analysis of UCD (HE, × 400); E: Pathological section analysis of FDCT (HE, × 200); F: Pathological section analysis of UCD together with FDCT (HE, × 200). HE: Hematoxylin and eosin; UCD: Unicentric Castleman disease; FDCT: Follicular dendritic cell tumor.](WJG-24-3958-g006){#F6}

DISCUSSION
==========

CD is a rare lymphoproliferative disease with a favorable prognosis; however, the pathogenesis of this disease is unclear. Munshi et al\[[@B5]\] showed that the incidence of CD is approximately 21/million. This disease can occur in all lymph nodes, especially in the mediastinum, neck, retroperitoneum and axillary regions; however, its occurrence in the retroperitoneal peripancreatic region is more rare\[[@B4]\]. The etiology of CD is thought to be related to herpes simplex virus 8 and HIV\[[@B6]-[@B7]\]. Another report confirmed that the pathogenesis of CD was closely related to the proliferation of T cells and B cells stimulated by interleukin 6\[[@B8]\]. CD mainly manifests as a painless enlargement of deep or superficial lymph nodes, and may be accompanied by fever, fatigue, anemia, night sweats, and an accelerated erythrocyte sedimentation rate\[[@B9]\]. The two cases in this report showed some differences in clinical manifestation. The tumor in Case 1 was found by physical examination without apparent patient discomfort, and the other was diagnosed by the symptoms of fever and fatigue. In addition, there was no obvious abdominal discomfort in either patient.

Retroperitoneal peripancreatic UCD is usually concealed and difficult to diagnose. In addition, there is no specific manifestation to distinguish it from a neuroendocrine tumor, paraganglioma, or lymphoma\[[@B10]\]. Imaging manifestations of the disease are very difficult to distinguish from other diseases, and the preoperative imaging diagnosis does not usually agree with the postoperative histopathological diagnosis. These difficulties can lead to misdiagnosis. Computed tomography (CT), MRI, and ultrasound can provide reference values for the diagnosis of retroperitoneal UCD. On CT imaging, retroperitoneal UCD is generally a well-defined mass with different morphologies, such as elliptical, kidney-shaped, and dumbbell-shaped, which can easily be distinguished from a spherical paraganglioma. In these two cases, both masses were oval in shape. The plain CT scan images of this disease show low or equal density lesions. The majority of lesions exhibit inhomogeneous enhancement on enhanced CT images. In addition, some tumors have a rich vascular supply, accompanied by microcalcifications\[[@B11]\]. On the MRI, most retroperitoneal UCD lesions show an iso-intense or hypo-intense signal on T1WI, and a slight hyperintense or hyperintense signal on T2WI. Although the enhanced scan characteristics are similar in both CT and MRI, MRI is superior to CT in terms of identifying the relationship between the mass and neighboring vessels or tissues\[[@B12]\]. In addition, ultrasound also has some advantages in estimating the location of the mass and its adjacent feeding vessels. In Case 2 in our report, we quickly clarified the location of the mass and its relationship with surrounding blood vessels (such as the inferior mesenteric artery and vein) using intraoperative ultrasonography, effectively reducing the risk of bleeding during resection of the mass and significantly improving the safety of surgery.

Due to the unclear specificity in clinical manifestations and imaging findings, the diagnosis of retroperitoneal peripancreatic UCD is still dependent on histopathology. In addition, different pathological types also have a direct impact on the treatment and prognosis of the disease. In general, CD can be classified into three types based on pathological characteristics: hyaline vascular type (HV), plasma cell type (PC) and mixed type. The percentage of HV type and PC type is approximately 90% and 10%, respectively. Mixed type cases are rarely reported. Most HV type cases manifest as UCD, while PC type cases usually occur in the form of multicentric CD\[[@B13]\]. In microscopic images of HV type, the centers of the huge folliculus lymphaticus are atrophied, blood vessels degenerate with hyaline vascular changes during this period, and a portion have an onion-like skin appearance\[[@B2],[@B14]-[@B15]\]. In microscopic images of PC type CD, the plasma cells are mainly spread throughout the interfollicular areas\[[@B16]\]. Pathologically, the two cases in this report were HV type UCD. In Case 1, mantle cell hyperplasia appeared as an onion-like skin surrounding a neurodegenerative vascularized germinal center. In Case 2, the single penetrated vessel appeared as a lollipop shape with hyaline degeneration.

At present, complete resection of the tumor is still the most effective treatment for retroperitoneal UCD with low recurrence and high cure rates\[[@B17]\]. However, recurrence has been reported in some cases, and both radiotherapy and chemotherapy were unsatisfactory for recurrent UCD\[[@B18]\]. Fortunately, no recurrence of retroperitoneal UCD was found in either of our two cases after surgery. During the resection of retroperitoneal UCD, special attention should be paid to the affected area between the tumor and surrounding vessels, tissues and organs, which is conducive to the complete resection of tumor and reducing blood loss during surgery. In Case 2, we performed laparoscopic resection of the tumor, which has the advantages of reduced surgical trauma, clear intraoperative vision, reduced intraoperative bleeding, high safety, and faster postoperative recovery. In Case 2, we found UCD together with follicular dendritic cell tumor (FDCT), which is a rare low-grade malignant tumor and may arise from CD\[[@B19]\]. However, it was difficult to determine whether the FDCT in Case 2 was secondary to CD. Surgical resection is the first choice in the treatment of FDCT, and recurrence has been observed after surgery. Adjuvant radiotherapy and chemotherapy can be followed after surgery, especially in patients with unresectable FDCT\[[@B20]\]. Case 2 did not undergo radiochemotherapy after surgery. We believe that the treatment of this patient was reasonable. In this report, we described two rare cases of retroperitoneal peripancreatic UCD, which will contribute to an improvement in the understanding of UCD and provide a significant reference for future cases.

ARTICLE HIGHLIGHTS
==================

Case characteristics
--------------------

Case 1 is a 48 year old female patient who presented with lymph node enlargement; and Case 2 is a 57 year old female patient who presented with tiredness and fever.

Clinical diagnosis
------------------

In Case 1, the patient initially had no apparent discomfort or noteworthy positive physical signs. In Case 2, the patient felt tired and had a fever with no other discomfort.

Differential diagnosis
----------------------

Neuroendocrine tumor, paraganglioma and lymphoma.

Laboratory diagnosis
--------------------

In Case 1, laboratory examinations revealed that the HIV antibody was negative. Carbohydrate antigen 19-9, carcinoembryonic antigen and other laboratory test results were also within the normal range. In Case 2, laboratory examinations showed that the HIV antibody was negative and the white blood cell count was 14.6 × 10^9^/L. Carbohydrate antigen 19-9, carcinoembryonic antigen and other laboratory test results were also within the normal range.

Imaging diagnosis
-----------------

In Case 1, MRI of the epigastrium showed that there was an elliptical hyperintense signal below the pancreas on the T1WI, and slight hyperintensity on the T2WI. In addition, marked enhancement on the arterial phase and reduced enhancement on the delayed phase were observed. In Case 2, MRI of the epigastrium showed that there was an elliptical hyperintense signal below the pancreas on the T1WI and slight hyperintensity on the T2WI. Marked enhancement on the arterial phase was inhomogeneous. In addition, the venous phase and delayed phase continued to intensify.

Pathological diagnosis
----------------------

In Case 1, the retroperitoneal single lymph node was compatible with Castleman disease. In addition, immunohistochemical staining revealed that cells were slightly positive for CD20, CD3, CD21, bcl-6, and bcl-2, a small number of cells were positive for CD138, and 20% of cells were positive for Ki-67. In Case 2, the diagnosis was retroperitoneal Castleman disease together with a follicular dendritic cell tumor. Immunohistochemical staining showed that a portion of cells were positive for CD21 and cells were negative for CK, a small number of cells were positive for S-100 and slightly positive for CD 1a and CD23, and about five percent of cells were positive for Ki-67.

Treatment
---------

In Case 1, laparotomy was performed to remove the retroperitoneal peripancreatic tumor without subsequent radiochemotherapy. In Case 2, laparoscopic surgery was performed to remove the retroperitoneal peripancreatic tumor without subsequent radiochemotherapy.

Related reports
---------------

Unicentric Castleman disease (UCD) is a rare disease of lymph nodes and related tissues, and occurrence in the retroperitoneal peripancreatic region is quite rare. Only a few cases of UCD together with follicular dendritic cell tumor have been identified. At present, complete resection of the tumor is still the most effective treatment for retroperitoneal peripancreatic UCD with low recurrence and high cure rates.

Term explanation
----------------

Follicular dendritic cell tumor is an uncommon neoplasm that has features of follicular dendritic cell differentiation, and typically presents as a slow-growing, painless mass without systemic symptoms. The tumor can occur on various parts of the body such as lymph nodes, tonsils, armpits and mediastinum, but is most common in the neck lymph nodes.

Experiences and lessons
-----------------------

At present, complete resection of the tumor is still the most effective treatment for retroperitoneal peripancreatic UCD with low recurrence and high cure rates. The diagnosis of retroperitoneal peripancreatic UCD is still dependent on histopathology. The two rare cases of retroperitoneal peripancreatic UCD included in this report will improve our understanding of this disease and provide a significant reference for future cases.
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